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Disclosure: only a first step
We applaud CMAJ’s recent focus on
the importance of disclosing conflicts
of interest in medical education1 and
research.2 However, disclosure is only a
first step toward mitigating commercial
influence, and too often it is viewed as
sufficient.
For example, at the last meeting of
the American Academy of Child and
Adolescent Psychiatry, hundreds of
presenters disclosed affiliations with
commercial supporters.3 However,
attendees considered the sessions “free
of commercial bias,” with a mean
rating of 9.17/10 on this item; the result
was celebrated as the product of a
“strong focus on conflict of interest and
disclosure issues.”4
Simply disclosing a conflict of inter-
est is inadequate because relationships
with industry are known to influence
physicians’ professional behaviour,5 and
the physician bias mediating the influ-
ence is largely unintentional.6 Further-
more, disclosures alone may provide
false reassurance by giving the appear-
ance that physician–industry relation-
ships have been adequately managed. In
fact, one study found that when a con-
flict of interest was disclosed, it had
greater, not less, influence.6
We must move beyond mere disclo-
sure of conflicts of interest toward
developing additional regulatory mech-
anisms aimed at minimizing their per-
vasive influence. Like George Wash-
ington admitting that he chopped down
his father’s cherry tree, our willingness
to disclose conflicts of interest does not
absolve us of further responsibility.
Elia Abi-Jaoude MSc MD
University Health Network, University of
Toronto, Toronto, Ont.
Daniel A. Gorman MD
University of Toronto, The Hospital for
Sick Children, Toronto, Ont.
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Advertising campaigns for
cystic fibrosis
As adults with cystic fibrosis, we have
benefited greatly from the work of the
Canadian Cystic Fibrosis Foundation.
Thanks to the foundation’s long-term
investment in research and care, people
with cystic fibrosis are living longer,
healthier lives. However, there is still
no cure — cystic fibrosis is the most
common, fatal genetic disease affecting
children and young adults in Canada.
There remains an urgent need to sup-
port future programs to help us fight
this devastating disease.
Unfortunately, in contrast to other
major diseases, cystic fibrosis is not
well-known or understood by Canadi-
ans. It is therefore vital that fund-
raising advertising campaigns present a
powerful and real depiction of what it’s
like to live with cystic fibrosis.
Before launching an advertising
campaign, the foundation consults and
receives input from the cystic fibrosis
community, including adults and par-
ents of children with the disease and
health care professionals. As leading
members of this community who
approved the current campaign, we rec-
ognize that its hard-hitting message may
affect some people negatively,1 and we
try very hard to minimize this impact.
Thanks to the foundation, its volunteer
chapters and the cystic fibrosis clinics
across Canada, our community receives
thoughtful communications that prepare
us for each advertising campaign and
explain the purpose of the campaign’s
message.
We strongly believe that the benefits
of increasing awareness, and ultimately
support, for cystic fibrosis research and
care will help all people with the dis-
ease and move us closer to a world
where cystic fibrosis is no longer a pro-
gressive, life-shortening disease.
Nathan Fish
Ontario representative, Adult Cystic
Fibrosis Committee, and Advertising
Campaign Working Group member,
Canadian Cystic Fibrosis Foundation,
Brantford, Ont.
Karen Gliddon
Hamilton and Area Chapter President, and
Adult Committee Chairperson, Executive
Committee, Canadian Cystic Fibrosis
Foundation, Brantford, Ont.
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Clinical guidelines may
need ethical component
The AGREE collaboration has intro-
duced a new research-based version of
its instrument to assess the quality of
clinical guidelines and the reporting of
the underlying development process.1,2
This version maintains the same six
quality-defining domains that under-
pinned the original AGREE approach:
scope and purpose; stakeholder
involvement; rigour of development;
clarity of presentation; applicability;
and editorial independence. By keeping
these domains, the AGREE collabora-
tors seem to imply that they do not con-
sider an extension necessary.
Perhaps the guidelines (and tools)
should explicitly help their users put
the clinical guidance offered into prac-
tice in ethically competent ways. As
acknowledged in the CanMEDS frame-
work,3 health care professionals need
robust ethical competence to provide
patient care. This is not only relevant in
dramatic life-or-death situations, but
also in the increasingly complex reality
of everyday practice, where potential
issues are usually less striking but far
more common and often no less impor-
tant.4
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It is premature to propose adding an
ethical component to the AGREE
domains. Instead, we advocate research
to explore how the codes of ethics for
different professions can be supple-
mented with treatment-specific materi-
als, how the process of developing such
materials can be systematized in the
spirit of AGREE, and how such materi-
als can be used to increase ethically
competent attitudes and behaviour in
everyday patient care.
W. Göttens-Jansen MSc MA
E. van Leeuwen PhD
IQ Healthcare, Section Ethics, Philosophy
and History of Medicine, Radboud
University, Nijmegen Medical Center
P.A.G.M. De Smet PhD
IQ Healthcare, Department of Clinical
Pharmacy, Radboud University, Nijmegen
Medical Center 
Jan K. Buitelaar MD PhD
Donders Institute of Brain, Cognition and
Behavior; Karakter Child and Adolescent
Psychiatry University Center; Radboud
University, Nijmegen Medical Center,
Nijmegen, The Netherlands
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Prostitution gender
Although much of the language in
Shannon’s article is carefully gender
neutral, the opening paragraph defines
prostitution with reference to women
only.1 Men working in the sex trade are
also victims of assault and murder. The
closeting of this aspect of the sex trade
along with other elements of gender
stereotyping impedes our ability to rec-
ognize patterns of nonconsensual vio-
lence or sex in men.
Helen C. Cluett
Prince Edward Family Health Team;
Quinte Health Care; Queen’s University,
Wellington, Ont.
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Correction: Canada’s prosti-
tution legislation
The article by Shannon refers to the
upcoming Ontario Supreme Court deci-
sion.1 In fact, it is the Ontario Superior
Court. CMAJ regrets any inconve-
nience this error may have caused.
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Letters to the editor
In submitting a letter, you automati-
cally consent to have it appear
online and/or in print. All letters
accepted for print will be edited by
CMAJ for space and style. Most ref-
erences and multiple authors’ names
and full affiliations will appear
online only. (The full version of any
letter accepted for print will be
posted at cmaj.ca.) 
Canadian Adverse Reaction Newsletter
Highlights from the October 2010 issue
 
•        Statins and interstitial lung disease
•        Potential interference of CT scanning with 
          electronic medical devices
•        Red Bull Energy Drink: 
          suspected association with seizure
•        New consumer form for reporting 
          adverse reactions
• Quarterly summary of advisories
      
 
Visit the MedEffectTM Canada Web site at 
www.healthcanada.gc.ca/medeffect to view or to 
subscribe for free to the Newsletter and other 
health product advisories.
         
Bulletin canadien des effets indésirables
Les grandes lignes du numéro d'octobre 2010
  
•  Les statines et la pneumopathie interstitielle
•  Interférence potentielle entre la tomodensitométrie 
    et des dispositifs médicaux électroniques
•  Red Bull Energy Drink : 
    lien soupçonné avec une crise d’épilepsie
•  Nouveau formulaire de déclaration des effets
    indésirables par le consommateur
•  Sommaire trimestriel des avis
 
Visitez le site Web MedEffetMC Canada à 
www.santecanada.gc.ca/medeffet pour consulter ou 
vous abonner gratuitement au Bulletin et aux avis sur 
les produits de santé.
         
letters-oct5_Layout 1  15/09/10  11:40 AM  Page 1547
